Carregant...
Development and evaluation of Desvenlafaxine loaded PLGA-chitosan nanoparticles for brain delivery
Depression is a debilitating psychiatric condition that remains the second most common cause of disability worldwide. Currently, depression affects more than 4 per cent of the world’s population. Most of the drugs intended for clinical management of depression augment the availability of neurotransm...
Guardat en:
| Publicat a: | Saudi Pharm J |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5605887/ https://ncbi.nlm.nih.gov/pubmed/28951668 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsps.2016.12.003 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|